Prne
July 16th, 2009
HENNIGSDORF, Germany - The Fetal Medicine Foundation (FMF) confirmed that BRAHMS KRYPTOR compact is fulfilling the requirements for first trimester biochemical screening.
Non-invasive biomarker tests together with the measurement of nuchal translucency (NT) allow the risk assessment of Down’s syndrome without jeopardising the fetus. Especially pregnant women under the age of 35 benefit from this approach. Ten years ago the Fetal Medicine Foundation (FMF) certified the BRAHMS KRYPTOR and took it into clinical routine as the first automated laboratory system for quality-assured combined first trimester screening. Now the compact version of the KRYPTOR follows. Professor Kevin Spencer from the King George Hospital in Essex conducted an evaluation of the first trimester Down’s screening assays Free sshCG and PAPP-A on the BRAHMS KRYPTOR compact. Based on this study he concluded that results from both systems are interchangeable and screening performance is equally. Thus both platforms will use the same set of medians.
“Medians are established over a long period of time and their stability is important to maintain an effective screening program. Since it has been established - because the KRYPTOR compact and KRYPTOR use exactly the same reagent system - the medians on each machine are interchangeable and therefore any lab wishing to change to compact would not need to re-evaluate medians. This has never been possible with any other analytical platform before,” explained Professor Spencer, who also serves as Director of Biochemical Screening of the Fetal Medicine Foundation (FMF).
Laboratories starting with KRYPTOR compact newly, can expect “that the screening performance using KRYPTOR compact will be equally as good as that which has been achieved with KRYPTOR over the past 10 years”.
Trisomy 21 or Down’s syndrome is one of the most common genetic abnormalities affecting one in every 700 births worldwide. The risk of chromosomal defects like Trisomy 21 increases with maternal age, but decreases with gestational age. Non-invasive testing allows all pregnant women to assess their individual risk without having to submit to invasive testing which is associated with a certain risk of miscarriage of about 1%. Non-invasive risk assessment requires high precision and accuracy in the measurement of the biochemical markers, as well as for the measurement of the nuchal translucency. For the BRAHMS markers Free sshCG and PAPP-A, KRYPTOR fulfils these requirements in an exceptional way, making KRYPTOR - and now KRYPTOR compact - the instrument of choice for 1st and 2nd trimester screening.
The evaluation was carried out over a six week period from March to April 2009 performed on one KRYPTOR compact and two KRYPTOR classic machines. To assess medians the research team used a group of 400 samples from Caucasian, non smoking women with a singleton pregnancy and with gestations in the range 10+0 to 13+6 weeks. The KRYPTOR compact medians are very close to the current FMF calculated median for KRYPTOR classic and suggest that deriving new medians for the new platform should not be necessary. The clinical utility of KRYPTOR and KRYPTOR compact was compared in a case control study in some 70 cases of known Trisomy 21. Both analytical platforms perform with excellent precision, the medians of KRYPTOR compact highly correlate with those established by the Fetal Medicine Foundation (FMF) using KRYPTOR in their routine from 1998 on.
The BRAHMS Aktiengesellschaft conducts researches, develops, produces and markets innovative diagnostic biomarkers. It is one of the three largest biotechnology companies in Germany. The company sells its products in more than 65 countries via its own subsidiary companies and sales organizations as well as laboratory systems from its own production and globally operating licensees. The headquarter of BRAHMS is at Hennigsdorf / Berlin, where about 220 out of 400 of the world wide employees of the company are posted.
The Fetal Medicine Foundation (FMF) is a Registered Charity that aims to improve the health of pregnant women and their babies through research and training in fetal medicine. The Foundation, with the support of an international group of experts, has introduced an educational programme both for healthcare professionals and parents and a series of certificates of competence in different aspects of fetal medicine. For further information visit www.fetalmedicine.com
Contact: BRAHMS Aktiengesellschaft Ingo Buchholzer Public Relations Manager Phone: +49 3302 883-637 Fax: +49-3302-883-635 Mobile: +49-172-323-4087 E-mail: i.buchholzer@brahms.de
www.brahms.de
Source: B R A H M S Aktiengesellschaft
Contact: BRAHMS Aktiengesellschaft, Ingo Buchholzer, Public Relations Manager, Phone: +49 3302 883-637, Fax: +49-3302-883-635, Mobile: +49-172-323-4087, E-mail: i.buchholzer at brahms.de
Filed under Biotechnology, Business, Clinical Trials / Medical Discoveries, Health, Health Care / Hospitals, Licensing / Marketing Agreements, New Products / Services, Pharmaceuticals | Tags: B R A H M S Aktiengesellschaft, Germany, Hennigsdorf | Comment Below
Related Press Releases RAYSPAN's Metamaterial Antennas Provide the Extended Range and WiFi Performance in NETGEAR's Ultimate Networking MachineSeptember 20th, 2009 SAN DIEGO -
RAYSPAN Corporation, the world's leading innovator of metamaterial air interface solutions, today announced that NETGEAR(R), Inc. (Nasdaq: NTGR), a worldwide provider of technologically innovative, branded networking solutions, has embedded the company's Metamaterial antennas in their newest high performance feature-rich wireless router, the RangeMax(TM) Dual Band Wireless-N Gigabit Router, (WNDR3700). Founder of Curidium Launches Elixior, an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine BusinessesSeptember 6th, 2009 LONDON - Elixior Limited, the advisory company focused on the development and growth of innovative personalized medicine businesses, announced today its launch by the founder and former CEO of Curidium, Dr Anne Bruinvels. Elixior's business activities are aimed at:
- Supporting the development and growth of personalized medicine businesses through the creation of partnerships and / or the sourcing of investments - Helping personalized medicine companies with the structuring of their corporate and commercial strategies - Conducting due diligence on personalized medicine ventures - Building a world-wide, personalized medicine knowledge-base to support cooperation between personalized medicine businesses and the growth of the sector. B-R-A-H-M-S and Thermo Fisher Scientific Join Forces to Create a Leader in Specialty DiagnosticsSeptember 2nd, 2009 HENNIGSDORF, Germany - B-R-A-H-M-S, a leading diagnostics company, and Thermo Fisher Scientific, the world leader in serving science, join forces to establish a European Center of Excellence for clinical diagnostics with a focus on innovative biomarkers. B-R-A-H-M-S announces the signature of a Share Purchase Agreement (SPA) with Thermo Fisher Scientific Inc. British Women are Wasting a Fortune Buying the Wrong FoundationAugust 23rd, 2009 LONDON -
- With Photo
Bobbi Brown Survey findings:
- The average British woman spends a whopping GBP125 and tries seven different foundations before finding the right one, according to a new survey* commissioned by Bobbi Brown Cosmetics. - 42% of British women say their worst beauty nightmare is a foundation 'tide line' (mask like effect, with different colour face & neck). The Foundation for Research in Osteoporosis and Bone Disease (FROMO) Awards the 2009 Fellowship in Renal Physiology and PathophysiologyJune 28th, 2009 GENEVA -
The Foundation for Research in Osteoporosis and Bone Disease (FROMO) announced the recipients of the 2009 Fellowship in Renal Physiology and Pathophysiology: Andreas Kistler, MD, PhD, Clinical Fellow at the Division of Nephrology of the University Hospital Zurich, Switzerland and Sara Damiano, PhD student in Nephrological Sciences at the Second University of Naples, Italy. The biotechnology company Amgen offered this educational grant to FROMO which is a Foundation based in Geneva to support research and teaching in the field of bone disease, in particular renal osteodystrophy which affects patients with severe renal insufficiency. BRAHMS, Cezanne and Lumiphore Announce Partnership for Diagnostic TestsJune 21st, 2009 BERLIN, NIMES, France and RICHMOND, California - Diagnostics company BRAHMS Aktiengesellschaft, Cezanne and Lumiphore Inc., a biotechnology leader from California, announced that they have signed an agreement on incorporation of Lumiphore's Lumi4(R)-Tb complexes in BRAHMS diagnostic tests. Under the agreement, BRAHMS together with its subsidiary Cezanne, developer and manufacturer of KRYPTOR automated diagnostic solutions, has the non-exclusive rights to incorporate Lumi4(R) technology into current and future diagnostic tests and the exclusive rights to use the technology in diagnostic tests for Down's Syndrome including Trisomy 21, 13 and 18, Triploidy, Translocation, and Mosaicism. ICON Announces Collaboration to Develop New Translational Medicine Unit at Purpose-built Hospital Facility in ManchesterJune 15th, 2009 DUBLIN - New Facility Part of Ambitious Expansion Plans at Central Manchester University Hospitals Foundation Trust Campus
ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has signed a collaborative agreement with the Central Manchester University Hospitals Foundation (CMFT) to develop a purpose built translational medicine facility. The new facility will form part of an ambitious expansion plan being undertaken by Central Manchester University Hospitals Foundation Trust (CMFT) to develop the existing Manchester Royal Infirmary (MRI) campus. Human Rights Solutions Forum Tackles Business DilemmasJune 9th, 2009 ISTANBUL - A web-based Solutions Forum to address and discuss human rights dilemmas for multi-national corporations was launched during the Global Compact Annual Local Network Forum in Istanbul. The Human Rights Solutions Forum is produced jointly by the UN Global Compact, Maplecroft and is funded by the GE Foundation, the philanthropic organization of General Electric Company. Author Declan Walsh Honored With National Leadership Award in Palliative MedicineMay 6th, 2009 PHILADELPHIA - Dr. Walsh is the Primary Editor of Palliative Medicine, a new Clinical Reference Published by Elsevier
Elsevier, the world's leading publisher of scientific, technical, and medical information products and services, congratulates Declan Walsh, MSc, FACP, FRCP (Edin) on receiving the American Academy of Hospice and Palliative Medicine's 2009 Project on Death in America (PDIA) Palliative Medicine National Leadership Award (www.aahpm.org/membership/awards.html) at the AAHPM 2009 Annual Assembly on March 26. Vesternet.com Today Officially Launches the Worlds First ZigBee Shop... Offering Development Tools, Components, Certified Products and a Platform for Management of DevicesApril 29th, 2009 DARESBURY, England - Vesternet has developed two core products: Zigbox - a compact ZigBee Ethernet gateway Zigbytes - a web-based user interface
Together they form the backbone of any network: Zigbox gathers sensor data... & Zigbytes presents it online.
Related News Hyundai rolls out new compact car i20December 28th, 2008 NEW DELHI - Auto major Hyundai Motors India Monday here launched its new hatchback 'i20' in the premium compact segment. The car is Hyundai's second venture in the premium compact segment, which the company managing director Heung Soo Lheem has described as the 'high growth segment' for the coming years. Indian boffins' baby mp3 heart monitor could save many livesAugust 29th, 2009 WASHINGTON - Scientists from Manoharbhai Patel Institute of Engineering and Technology, in Gondia, India have developed a novel fetal heart monitor that could save the lives of unborn infants in complicated pregnancies. Dr A.K. Mittra and colleagues have come up with a simple device that is based on a two-microphone system that can monitor fetal heart rate during the mother's rest times and sleep and send an alert to the woman and her physician. Appeal planned for ruling that allows company to dispose of Italy's nuclear waste in UtahJune 4th, 2009 Fight against foreign nuke waste in Utah continuesSALT LAKE CITY — An eight-state radioactive-waste-management entity plans to appeal a federal court ruling that said a company can dispose of foreign nuclear waste at its facility in the western Utah desert. A judge last month ruled against the Northwest Compact, which includes Utah and seven other states. Ford to make low-cost compact car in India as US automaker targets fast-growing AsiaSeptember 23rd, 2009 Ford to make low-cost compact car in IndiaNEW DELHI — Ford Motor Co. will manufacture a low-cost compact car in India from early next year, the automaker said Wednesday, as it seeks to boost sales in fast-growing Asia. Alpha Natural to buy Foundation Coal for about $1.4B, create one of biggest US coal producersMay 12th, 2009 Alpha Natural to buy Foundation Coal for $1.4BABINGDON, Va. — Alpha Natural Resources says it will buy Foundation Coal Holdings for approximately $1.4 billion, creating one of the nation's largest coal producers. New York Times Co. Foundation suspends new grants, shrinks college scholarship programApril 24th, 2009 New York Times Co. Foundation suspends new grantsNEW YORK — The New York Times Company Foundation will suspend new grant awards and matching gifts because of the financial strains brought on by the recession. Galactic freak could reveal how galaxies formMarch 25th, 2009 SYDNEY - Astronomers have located a galactic freak, an extremely rare ultra-compact dwarf galaxy, that could be the missing link in understanding how galaxies and their clusters evolve. The dwarf galaxy, which is the closest yet found to Earth, is far brighter and more massive than the clusters of stars that usually surround galaxies, and was born in the very early stages of the formation of the universe. Honda ventures into the compact market (Lead)June 11th, 2009 NEW DELHI - A day after the Japanese car maker Honda celebrated 50 years of venturing overseas, the company Wednesday launched Jazz, its first compact offering for the Indian market. "In the 12 years in India, we have had products only in the premium sedan categories. Maruti launches hatchback Ritz, its 12th compact carMay 15th, 2009 NEW DELHI - India's largest carmaker Maruti Suzuki Friday rolled out its 12th compact model Ritz, a hatchback, priced between Rs.390,000 and Rs.480,000 for the petrol version. The diesel variant will cost between Rs.465,000 and Rs.499,000 in the national capital, top officials of the company said here. Indian American leads project to make CFLs more efficientApril 8th, 2009 TORONTO - Compact fluorescent lightbulbs (CFLs) use just one-third of the energy that old incandescent bulbs use to provide the same amount of light. Now CFLs are going to be even more efficient, thanks to research being led by an Indian American scientist.
|
|
